This is the American ICD-10-CM version of E88.09 - other international versions of ICD-10 E88.09 may differ. All neoplasms, whether functionally active or not, are classified in Chapter 2.
2016 2017 2018 2019 Billable/Specific Code. E88.09 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Short description: Oth disorders of plasma-protein metabolism, NEC.
Pseudocholinesterase deficiency ICD-10-CM E88.09 is grouped within Diagnostic Related Group (s) (MS-DRG v38.0): 826 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with mcc 827 Myeloproliferative disorders or poorly differentiated neoplasms with major o.r. Procedures with cc
Other abnormalities of plasma proteins 1 R77 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail. 2 The 2021 edition of ICD-10-CM R77 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of R77 - other international versions of ICD-10 R77 may differ.
2016 2017 2018 2019 2020 2021 Non-Billable/Non-Specific Code. R77 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
273.8 is a legacy non-billable code used to specify a medical diagnosis of other disorders of plasma protein metabolism. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
The following crosswalk between ICD-9 to ICD-10 is based based on the General Equivalence Mappings (GEMS) information:
Your blood is living tissue made up of liquid and solids. The liquid part, called plasma, is made of water, salts and protein. Over half of your blood is plasma. The solid part of your blood contains red blood cells, white blood cells and platelets.
General Equivalence Map Definitions The ICD-9 and ICD-10 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.